132 related articles for article (PubMed ID: 32405990)
21. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
Borges-Neto S; Tuttle RH; Shaw LK; Smith WT; Jain D; Coleman RE; Whellan D
Radiology; 2004 Jul; 232(1):58-65. PubMed ID: 15220493
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m-tetrofosmin scintigraphy, P-glycoprotein and lung cancer.
Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J
J Nucl Med; 1998 Oct; 39(10):1830-1. PubMed ID: 9776299
[No Abstract] [Full Text] [Related]
23. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
[TBL] [Abstract][Full Text] [Related]
24. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
Kosuda S; Yokoyama H; Katayama M; Yokokawa T; Kusano S; Yamamoto O
Eur J Nucl Med; 1995 Oct; 22(10):1218-20. PubMed ID: 8542909
[TBL] [Abstract][Full Text] [Related]
25. A comparison of Tl-201, Tc-99m sestamibi, and Tc-99m tetrofosmin myocardial perfusion scintigraphy in patients with mild to moderate coronary stenosis.
Reyes E; Loong CY; Harbinson M; Rahman S; Prvulovich E; Ell PJ; Anagnostopoulos C; Underwood SR
J Nucl Cardiol; 2006 Jul; 13(4):488-94. PubMed ID: 16919572
[TBL] [Abstract][Full Text] [Related]
26. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
[TBL] [Abstract][Full Text] [Related]
28. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice.
Hambÿe AS; Delsarte P; Vervaet AM
Nucl Med Commun; 2007 May; 28(5):383-90. PubMed ID: 17414888
[TBL] [Abstract][Full Text] [Related]
29. Tc-99m tetrofosmin. A new diagnostic tracer for parathyroid imaging.
Ishibashi M; Nishida H; Kumabe T; Morita S; Matoba F; Nomura G; Hayabuchi N
Clin Nucl Med; 1995 Oct; 20(10):902-5. PubMed ID: 8616997
[TBL] [Abstract][Full Text] [Related]
30. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M
Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941
[TBL] [Abstract][Full Text] [Related]
32. Tetrofosmin thyroid scintigraphy.
Klain M; Cuocolo A; Salvatore M; Maurea S
Eur J Nucl Med; 1998 Jul; 25(7):816. PubMed ID: 9741994
[No Abstract] [Full Text] [Related]
33. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
34. The Role of [
El Mantani Ordoulidis S; Siampanopoulou M
J Nucl Med Technol; 2023 Dec; 51(4):331-332. PubMed ID: 37433674
[TBL] [Abstract][Full Text] [Related]
35. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
[TBL] [Abstract][Full Text] [Related]
36. Exploring a technique for reducing the influence of scattered rays from surrounding organs to the heart during myocardial perfusion scintigraphy with technetium-99m sestamibi and technetium-99m tetrofosmin.
Monzen H; Hara M; Hirata M; Nakanishi A; Ogasawara M; Suzuki T; Sato T; Shimoyama H; Tadehara F; Hirose K; Yuki R
Ann Nucl Med; 2006 Dec; 20(10):705-10. PubMed ID: 17385311
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
Mansi L; Rambaldi PF; Marino G; Pecori B; Del Vecchio E
Clin Nucl Med; 1996 Sep; 21(9):700-3. PubMed ID: 8879870
[TBL] [Abstract][Full Text] [Related]
38. A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions.
Obwegeser R; Berghammer P; Rodrigues M; Granegger S; Hohlagschwandtner M; Kucera H; Singer C; Berger A; Kubista E; Sinzinger H
Eur J Nucl Med; 1999 Dec; 26(12):1553-9. PubMed ID: 10638406
[TBL] [Abstract][Full Text] [Related]
39. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
Gallowitsch HJ; Kresnik E; Mikosch P; Pipam W; Gomez I; Lind P
Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
[TBL] [Abstract][Full Text] [Related]
40. Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi.
Adams GL; Shaw LK; Tuttle RH; Hanson MW; Pagnanelli R; Borges-Neto S
Nucl Med Commun; 2007 Jun; 28(6):457-63. PubMed ID: 17460536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]